ATH-1020

N/A

Report date: 2025/05/22 15:16:48
NME

Base Information

Drug NameATH-1020
Drug Alias NameATH-1020
ClassificationSmall molecules
Mechanisms of ActionHepatocyte growth factor stimulantsHepatocyte growth factor receptor agonists
TargetsHepatocyte growth factorHepatocyte growth factor receptor
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAthira Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesAthira Pharma Inc
Inactive CompaniesN/A
Active IndicationsNerve Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A